$Omeros (OMER.US)$
how long will the hold off volume before reaching above 30

$Omeros (OMER.US)$  Clean movement.

$Omeros (OMER.US)$
Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
Omeros (OMER) announced successful results from its narsoplimab pivotal trial for treating transplant-associated thrombotic microangiopathy (TA-TMA). The primary statistical analysis showed that patients treated with narsoplimab had an over 3-fold reduction in mortality risk (hazard ratio = 0.32) compared to untreated p...

$Omeros (OMER.US)$ Omeros' Narsoplimab Meets Its Pivotal Trial Primary Endpoint!    Omeros Corp: To Resubmit a Bla to FDA for Narsoplimab

$Omeros (OMER.US)$ Straight to 15

$Omeros (OMER.US)$ Sky rocket

$Omeros (OMER.US)$ naughty naughty . go back to your room .

$Omeros (OMER.US)$ Weak hand lose their shares.

$Omeros (OMER.US)$ Going to rise.

$Omeros (OMER.US)$ Rise fast drop fast